Middle East & Africa Hematuria Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Treatment (Drugs, Therapies, and Others), Indication (Urinary Tract Infections, Kidney Stones, Urethritis, Blood Cancer, Bladder Stones, Prostate Cancer, Cystitis, Trauma, Vigorous Exercise, Polycystic Kidney Disease, Endometriosis, and Menstruation), Type (Macroscopic Hematuria, Microscopic Hematuria, Idiopathic Hematuria, and Jogger’s Hematuria), End User (Hospitals, Clinics, and Ambulatory Surgical Centers, and Others)
Market Introduction
Hematuria is a medical condition where presence of blood is found in the urine. Generally, urine does not contain RBC and hence this can result in serious issue that may also cause kidney stones, urinary tract infection and other inherited diseases.
Moreover, the high prevalence hematuria associated indications is expected to bolster the market growth during the forecast period. However, undiagnosed cases of associated indications limit the growth of the Middle East & Africa hematuria treatment market.
In the MEA region, the number of patients hospitalized in intensive care units (ICU) is rising, as is the number of pharmaceuticals prescribed, creating many diagnostic and therapeutic problems for already overburdened healthcare systems. COVID-19 symptoms are mostly seen in the pulmonary system, but urogenital manifestations and/or consequences are given special attention. The risk of serious infection is higher in older patients with CKD, and AKI is linked to a high fatality rate. Thus, it was necessary to monitor the kidney function of patients with severe COVID-19, and CRRT for protecting kidney function and cytokine elimination for critically ill patients was critical to improving recovery. COVID-19 infection, on the other hand, appears to have ramifications for the urogenital tract. When treating COVID-19, urogenital organs should be considered.
Market Overview and Dynamics
The Middle East & Africa hematuria treatment market is projected to reach US$ 46.8 million by 2028 from US$ 42.0 million in 2021; it is anticipated to grow at a CAGR of 1.5% from 2021 to 2028. Chronic kidney disease (CKD) is a common and life-threatening condition that affects a larger population. There are various types of CKDs, such as kidney stones, glomerulonephritis, polycystic kidney disease, and urinary tract infections. CKD is one of the key causes behind the prevalence of hematuria. In addition, the prevalence of UTI among women over 65 years of age is about 20% compared to the overall population, which is about 11%. Currently, the Middle East & Africa hematuria treatment market is gaining significantly from the increasing prevalence of associated indications.
Key Market Segments
In terms of type, the macroscopic hematuria segment accounted for the largest share of the Middle East & Africa hematuria treatment market in 2020. In terms of treatment, the drugs segment accounted for the largest share of the Middle East & Africa hematuria treatment market in 2020. In terms of indication, the urinary tract infection segment accounted for the largest share of the Middle East & Africa hematuria treatment market in 2020. In terms of end user, the hospitals segment accounted for the largest share of the Middle East & Africa hematuria treatment market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the hematuria treatment market in Middle East & Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are AstraZeneca, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline plc., Janssen Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd, and Boehringer Ingelheim International GmbH.
Reasons to Buy Report
- To understand the Middle East & Africa hematuria treatment market landscape and identify market segments that are likely to guarantee a strong return
- To comprehend the ever-changing market landscape and stay ahead in competition
- To efficiently plan merger and acquisition, and partnership deals in the Middle East & Africa hematuria treatment market by identifying segments with the most promising probable sales
- To make knowledgeable business decisions from perceptive and comprehensive analysis of the market performance of various segments
- To obtain market revenue forecast of the Middle East & Africa hematuria treatment market based on various segments for the period 2021–2028
MIDDLE EAST & AFRICA HEMATURIA TREATMENT MARKET SEGMENTATION
- Drugs
- Therapies
- Others
By Indication
- Urinary Tract Infections
- Kidney Stones
- Urethritis
- Blood Cancer
- Bladder Stones
- Prostate Cancer
- Cystitis
- Trauma
- Vigorous Exercise
- Polycystic Kidney Disease
- Endometriosis
- Menstruation
By Type
- Macroscopic Hematuria
- Microscopic Hematuria
- Idiopathic Hematuria
- Jogger’s Hematuria
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers (ASC's)
- Others
By Country
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Companies Mentioned
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Hematuria Treatment Market – By Treatment
1.3.2 Middle East & Africa Hematuria Treatment Market – By Indication
1.3.3 Middle East & Africa Hematuria Treatment Market – By Type
1.3.4 Middle East & Africa Hematuria Treatment Market – By End User
1.3.5 Middle East & Africa Hematuria Treatment Market – By Country
2. Middle East & Africa Hematuria Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hematuria Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa – PEST Analysis
4.3 Experts Opinion
5. Hematuria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Hematuria-Associated Indications
5.1.2 Increasing Awareness About Treatment Options and Improving Healthcare Expenditure
5.2 Market Restraints
5.2.1 Undiagnosed Cases of Associated Indications
5.3 Market Opportunities
5.3.1 Increasing Opportunities for Related Treatments
5.4 Future Trends
5.4.1 Rise in Preference for Advanced Therapies
5.5 Impact Analysis
6. Hematuria Treatment Market – Middle East & Africa Analysis
6.1 Middle East & Africa Hematuria Treatment Market Revenue Forecast and Analysis
7. Hematuria Treatment Market Revenue and Forecast To 2028 – By Treatment
7.1 Overview
7.2 Middle East & Africa Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
7.3 Drugs
7.3.1 Overview
7.3.2 Drugs: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Therapies
7.4.1 Overview
7.4.2 Therapies: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Others
7.5.1 Overview
7.5.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8. Hematuria Treatment Market Revenue and Forecast To 2028 – By Indication
8.1 Overview
8.2 Middle East & Africa Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
8.3 Kidney Stones
8.3.1 Overview
8.3.2 Kidney Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Urinary Tract Infections (UTI)
8.4.1 Overview
8.4.2 Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Urethritis
8.5.1 Overview
8.5.2 Urethritis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Blood Cancer
8.6.1 Overview
8.6.2 Blood Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Bladder Stones
8.7.1 Overview
8.7.2 Bladder Stones: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Prostate Cancer
8.8.1 Overview
8.8.2 Prostate Cancer: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.9 Cystitis
8.9.1 Overview
8.9.2 Cystitis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.10 Trauma
8.10.1 Overview
8.10.2 Trauma: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.11 Vigorous Exercise
8.11.1 Overview
8.11.2 Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.12 Polycystic Kidney Disease
8.12.1 Overview
8.12.2 Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.13 Endometriosis
8.13.1 Overview
8.13.2 Endometriosis: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
8.14 Menstruation
8.14.1 Overview
8.14.2 Menstruation: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
9. Hematuria Treatment Market Revenue and Forecast To 2028 – By Type
9.1 Overview
9.2 Middle East & Africa Hematuria Treatment Market, By Type 2020 & 2028 (%)
9.3 Macroscopic Hematuria
9.3.1 Overview
9.3.2 Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.4 Microscopic Hematuria
9.4.1 Overview
9.4.2 Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.5 Idiopathic Hematuria
9.5.1 Overview
9.5.2 Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
9.6 Jogger’s Hematuria
9.6.1 Overview
9.6.2 Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
10. Hematuria Treatment Market Revenue and Forecast To 2028 – By End User
10.1 Overview
10.2 Middle East & Africa Hematuria Treatment Market Share by End User 2020 & 2028 (%)
10.3 Hospitals
10.3.1 Overview
10.3.2 Hospitals: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.4 Clinics
10.4.1 Overview
10.4.2 Clinics: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.5 Ambulatory Surgical Centers (ASC’s)
10.5.1 Overview
10.5.2 Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
10.6 Others
10.6.1 Overview
10.6.2 Others: Hematuria Treatment Market Revenue and Forecast to 2028 (US$ Mn)
11. Middle East & Africa Hematuria Treatment Market – Geographic Analysis
11.1 Middle East & Africa: Hematuria Treatment Market
11.1.1 Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.2 Middle East & Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.3 Middle East & Africa: Hematuria Treatment Market, by Indication - Revenue and Forecast to 2028 (USD Million)
11.1.4 Middle East & Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.1.5 Middle East & Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.1.6 Middle East & Africa: Hematuria Treatment Market, by Country, 2021& 2028 (%)
11.1.6.1 Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.1.1 Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.1.2 Saudi Arabia: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.6.1.3 Saudi Arabia: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.1.6.1.4 Saudi Arabia: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.1.6.1.5 Saudi Arabia: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.1.6.2 South Africa: Hematuria Treatment Market- Revenue and Forecast to 2028 (USD Million)
11.1.6.2.1 South Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.2.2 South Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.6.2.3 South Africa: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.1.6.2.4 South Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.1.6.2.5 South Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.1.6.3 UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.3.1 UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.3.2 UAE: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.6.3.3 UAE: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.1.6.3.4 UAE: Hematuria Treatment Market, by Type - Revenue and Forecast to 2028 (USD Million)
11.1.6.3.5 UAE: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
11.1.6.4 Rest of Middle East & Africa: Hematuria Treatment Market- Revenue and Forecast to 2028 (USD Million)
11.1.6.4.1 Rest of Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
11.1.6.4.2 Rest of Middle East & Africa: Hematuria Treatment Market, by Treatment- Revenue and Forecast to 2028 (USD Million)
11.1.6.4.3 Rest of Middle East & Africa: Hematuria Treatment Market, by Indication- Revenue and Forecast to 2028 (USD Million)
11.1.6.4.4 Rest of Middle East & Africa: Hematuria Treatment Market, by Type- Revenue and Forecast to 2028 (USD Million)
11.1.6.4.5 Rest of Middle East & Africa: Hematuria Treatment Market, by End User- Revenue and Forecast to 2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Hematuria Treatment Market
12.1 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13. Hematuria Treatment Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Bristol-Myers Squibb Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 F. HOFFMANN-LA ROCHE LTD.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline Plc
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Janssen Pharmaceuticals
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck & Co., Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Novartis AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sun Pharmaceutical Industries Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Boehringer Ingelheim International GmbH
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East & Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 2. Middle East & Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 3. Middle East & Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 4. Middle East & Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Saudi Arabia Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 6. Saudi Arabia Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 7. Saudi Arabia Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 8. Saudi Arabia Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. South Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 10. South Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 11. South Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. UAE Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 14. UAE Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 15. UAE Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 16. UAE Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Middle East & Africa Hematuria Treatment Market, by Treatment – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Middle East & Africa Hematuria Treatment Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Middle East & Africa Hematuria Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of Middle East & Africa Hematuria Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies
Table 23. Glossary of Terms, Hematuria Treatment Market
LIST OF FIGURES
Figure 1. Hematuria Treatment Market Segmentation
Figure 2. Middle East & Africa Hematuria Treatment Market Overview
Figure 3. Macroscopic Hematuria Segment Held the Largest Share of the Type Segment in Hematuria Treatment Market
Figure 4. UAE to Show Significant Growth During Forecast Period
Figure 5. Middle East & Africa Hematuria Treatment Market, Industry Landscape
Figure 6. Middle East & Africa PEST Analysis
Figure 7. Hematuria Treatment Market Impact Analysis of Drivers and Restraints
Figure 8. Middle East & Africa Hematuria Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Middle East & Africa Hematuria Treatment Market Share by Treatment 2020 & 2028 (%)
Figure 10. Drugs: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 11. Therapies: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 12. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 13. Middle East & Africa Hematuria Treatment Market Share by Indication 2020 & 2028 (%)
Figure 14. Kidney Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 15. Urinary Tract Infections: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 16. Urethritis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 17. Blood Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 18. Bladder Stones: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 19. Prostate Cancer: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 20. Cystitis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 21. Trauma: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 22. Vigorous Exercise: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 23. Polycystic Kidney Disease: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 24. Endometriosis: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 25. Menstruation: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 26. Middle East & Africa Hematuria Treatment Market, by Type 2020 & 2028 (%)
Figure 27. Macroscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 28. Microscopic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 29. Idiopathic Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 30. Jogger’s Hematuria: Hematuria Treatment Market Revenue and Forecast to 2028(US$ Mn)
Figure 31. Middle East & Africa Hematuria Treatment Market Share by End User 2020 & 2028 (%)
Figure 32. Hospitals: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 33. Clinics: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 34. Ambulatory Surgical Centers: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 35. Others: Hematuria Treatment Market Revenue and Forecast To 2028 (US$ Mn)
Figure 36. Middle East & Africa: Hematuria Treatment Market, by Key Country – Revenue (2021) (USD Million)
Figure 37. Middle East & Africa Hematuria Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 38. Middle East & Africa: Hematuria Treatment Market, by Country, 2021& 2028 (%)
Figure 39. Saudi Arabia: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 40. South Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 41. UAE: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 42. Rest of Middle East & Africa: Hematuria Treatment Market– Revenue and Forecast to 2028 (USD Million)
Figure 43. Impact Of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 44. Growth Strategies Done by the Companies in the Market, (%)
- AstraZeneca
- Bristol-Myers Squibb Company
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline plc.
- Janssen Pharmaceuticals
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd
- Boehringer Ingelheim International GmbH
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa hematuria treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa hematuria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.